Indocyanine Green is named as an intervention in 5 current clinical trials in our China and USA registers. 3 are recruiting patients now. The most common phase is Phase 4. The sponsor with the most trials is Shanghai Jiao Tong University Affiliated Sixth People's Hospital (2). The most-studied condition is Lower Extremity Lymphedema.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
NCT07613931 · Lower Extremity Lymphedema
|
Phase EARLY_PHASE1 | Recruiting | Tactile Medical | USA |
|
Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery
NCT07315828 · ClinicalTrials.gov ↗ · Giant Cell Tumor of Bone
|
Phase 4 | Recruiting | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | China |
|
Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery
NCT07315841 · ClinicalTrials.gov ↗ · Tenosynovial Giant Cell Tumor
|
Phase 4 | Recruiting | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | China |
|
Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
NCT06979115 · ClinicalTrials.gov ↗ · Bone Neoplasms, Soft Tissue Neoplasms
|
Observational | Not yet open | Guangdong Provincial People's Hospital | China |
|
IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
NCT04611997 · ClinicalTrials.gov ↗ · Gastric Cancer, Lymph Node Metastases
|
Phase 3 | Active, closed | Fujian Medical University | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
1 single-substance product containing Indocyanine Green on the HPRA medicines list.
No entry for Indocyanine Green in the EMA, FDA or German BfArM shortage lists we track.
| Lead sponsor | Trials |
|---|---|
| Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 2 |
| Tactile Medical | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Fujian Medical University | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 4 | 2 |
| Clinical trials in USA | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
5 current trials in our China and USA registers name Indocyanine Green as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of the 5 trials are recruiting: 2 with sites in China and 1 with sites in USA. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Shanghai Jiao Tong University Affiliated Sixth People's Hospital (2), Tactile Medical (1), Guangdong Provincial People's Hospital (1) and Fujian Medical University (1). The number in brackets is how many trials each organisation leads.
Yes. The HPRA medicines list includes 1 single-substance product containing Indocyanine Green, for example Verdye 5 mg/ml powder for solution for injection (Diagnostic Green Limited). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
Not in the lists we track: Indocyanine Green has no entry in the EMA, FDA or German BfArM shortage registers as of their latest sync.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Indocyanine Green works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Indocyanine Green works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Indocyanine Green (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.